The presence of a GnRH/GnRH-R axis associated with antitumor activities in PCa and specifically in CRPC cells supports the notion that it might be considered an additional direct target of GnRH analog-based (agonists and antagonists) ADT. The gene discussed is GNRHR; the disease is posterior cortical atrophy.